Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05580770
Title Mirdametinib + BGB-3245 in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors SpringWorks Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center RECRUITING La Jolla California 92093 United States Details
Yale-New Haven Hospital-Yale Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Orlando Health Cancer Institute WITHDRAWN Orlando Florida 32806 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
Hospital of the University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center RECRUITING Dallas Texas 75246 United States Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
Calvary Mater Newcastle RECRUITING Waratah 2298 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field